Gerald Cochran1, Adam J Gordon2, Craig Field3, Jennifer Bacci4, Ranjita Dhital5, Thomas Ylioja6, Maxine Stitzer7, Thomas Kelly8, Ralph Tarter4. 1. University of Pittsburgh School of Social Work, 4200 Fifth Ave., Pittsburgh, PA 15260, USA; University of Pittsburgh, Department of Psychiatry, 3811, Pittsburgh, PA 15213, USA. Electronic address: gcochran@pitt.edu. 2. University of Pittsburgh School of Medicine, Department of Medicine, M240 Scaife Hall, 3550 Terrace St, Pittsburgh, PA 15261, USA; VA Pittsburgh Healthcare System, University Drive C (151-C), Pittsburgh, PA 15240-1001, USA. 3. University of Texas El Paso, Department of Psychology, El Paso, TX 79968, USA. 4. University of Pittsburgh School of Pharmacy, 501 Terrace St, Pittsburgh, PA 15213, USA. 5. Florence Nightingale Faculty of Nursing and Midwifery, King's College London, James Clerk Maxwell Building, 57 Waterloo Road, London SE1 8WA, UK. 6. University of Pittsburgh School of Social Work, 4200 Fifth Ave., Pittsburgh, PA 15260, USA. 7. Johns Hopkins Medicine, Behavioral Pharmacology Research Unit, 5510 Nathan Shock Drive, Baltimore, MD 21224-6823, USA. 8. University of Pittsburgh, Department of Psychiatry, 3811, Pittsburgh, PA 15213, USA.
Abstract
BACKGROUND: Prescription opioid misuse is a major public health concern in the US. Few resources exist to support community pharmacists engaging patients who misuse or are at risk for misuse. OBJECTIVES: This report describes the results of the execution of the ADAPT-ITT model (a model for modifying evidence-based behavioral interventions to new populations and service settings) to guide the development of a behavioral health framework for opioid medication misuse in the community pharmacy setting. METHODS: Pharmacy, addiction, intervention, and treatment experts were convened to attend a one-day meeting to review the empirical knowledgebase and discuss adapting the screening, brief intervention, and referral to treatment (SBIRT) protocol for addressing opioid medication misuse in community pharmacy. Qualitative data gathered from the meeting were analyzed by 2 independent coders in a 2-cycle process using objective coding schemes. Percentage of agreement and Cohen's Kappa were calculated to assess coder agreement. RESULTS: First-cycle coding identified 4 distinct themes, with coder percentage of agreement ranging from 93.5 to 99.6% and with Kappa values between 0.81 and 0.93. Second-cycle coding identified 10 sub-themes, with coder percentage of agreement ranging from 83 to 99.8% and with Kappa values between 0.58 and 0.93. Identified themes and sub-themes encompassed patient identification, intervention, prevention, and referral to treatment. CONCLUSIONS: Focus of screening efforts in the emerging model should capitalize on pharmacists' knowledge of medication management. Screening likewise should be multidimensional in order to facilitate patient-centered interventions that activate additional disciplines able to interface with patients at risk or involved in medication misuse.
BACKGROUND: Prescription opioid misuse is a major public health concern in the US. Few resources exist to support community pharmacists engaging patients who misuse or are at risk for misuse. OBJECTIVES: This report describes the results of the execution of the ADAPT-ITT model (a model for modifying evidence-based behavioral interventions to new populations and service settings) to guide the development of a behavioral health framework for opioid medication misuse in the community pharmacy setting. METHODS: Pharmacy, addiction, intervention, and treatment experts were convened to attend a one-day meeting to review the empirical knowledgebase and discuss adapting the screening, brief intervention, and referral to treatment (SBIRT) protocol for addressing opioid medication misuse in community pharmacy. Qualitative data gathered from the meeting were analyzed by 2 independent coders in a 2-cycle process using objective coding schemes. Percentage of agreement and Cohen's Kappa were calculated to assess coder agreement. RESULTS: First-cycle coding identified 4 distinct themes, with coder percentage of agreement ranging from 93.5 to 99.6% and with Kappa values between 0.81 and 0.93. Second-cycle coding identified 10 sub-themes, with coder percentage of agreement ranging from 83 to 99.8% and with Kappa values between 0.58 and 0.93. Identified themes and sub-themes encompassed patient identification, intervention, prevention, and referral to treatment. CONCLUSIONS: Focus of screening efforts in the emerging model should capitalize on pharmacists' knowledge of medication management. Screening likewise should be multidimensional in order to facilitate patient-centered interventions that activate additional disciplines able to interface with patients at risk or involved in medication misuse.
Authors: Meera Viswanathan; Leila C Kahwati; Carol E Golin; Susan J Blalock; Emmanuel Coker-Schwimmer; Rachael Posey; Kathleen N Lohr Journal: JAMA Intern Med Date: 2015-01 Impact factor: 21.873
Authors: Gerald Cochran; Jennifer L Bacci; Thomas Ylioja; Valerie Hruschak; Sharon Miller; Amy L Seybert; Ralph Tarter Journal: J Am Pharm Assoc (2003) Date: 2016-03-24
Authors: Brian C Shonesy; Donald Williams; Damian Simmons; Erin Dorval; Stuart Gitlow; Richard M Gustin Journal: J Addict Med Date: 2019 Sep/Oct Impact factor: 3.702
Authors: Vanessa M McMahan; Justine Arenander; Tim Matheson; Audrey M Lambert; Sarah Brennan; Traci C Green; Alexander Y Walley; Phillip O Coffin Journal: JMIR Form Res Date: 2022-09-07